Skip to main content
. 1999 Jul 20;96(15):8639–8644. doi: 10.1073/pnas.96.15.8639

Figure 3.

Figure 3

CD8+ minor H antigen-specific CTL clone DRN-7 specifically inhibits engraftment of 10885 AML cells in NOD/SCID mice. Mean (±SE) engraftment of human cells in mice transplanted with 10885 AML cells cultured with either the control clone DRN-11 (open columns) or with clone DRN-7 (filled columns), at 29–32 days (1 month) or 65–70 days (2 months). The data are expressed as a percentage of the mean engraftment in control mice who received the same dose of 10885 AML cells cultured in medium alone. The numbers of control, DRN-11-treated, and DRN-7-treated mice analyzed at 1 month were 5, 3, and 5, respectively, and at 2 months, 6, 2, and 6, respectively. P values refer to the comparison between the engraftment in DRN-7-treated mice and that in control mice, as computed by the Mann–Whitney u test.